Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
暂无分享,去创建一个
[1] S. Mandel,et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[2] Jee Soo Kim,et al. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma. , 2017, Oral oncology.
[3] Su-jin Kim,et al. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer , 2015, PloS one.
[4] Tae Yong Kim,et al. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer. , 2017, Thyroid : official journal of the American Thyroid Association.
[5] B. Lang,et al. Staging Systems for Papillary Thyroid Carcinoma: A Review and Comparison , 2007, Annals of surgery.
[6] Samuel L. Oyer,et al. Reevaluating the Prognostic Significance of Age in Differentiated Thyroid Cancer , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[7] E. Pribitkin,et al. Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer? , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[8] J. Shah,et al. Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? , 2015, Thyroid : official journal of the American Thyroid Association.
[9] T. Klonisch,et al. Prognostic nomograms to predict oncological outcome of thyroid cancers. , 2013, The Journal of clinical endocrinology and metabolism.
[10] J. Jonklaas,et al. The impact of age and gender on papillary thyroid cancer survival. , 2012, The Journal of clinical endocrinology and metabolism.
[11] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[12] S. Roman,et al. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Frederick L. Greene,et al. The Eighth Edition of TNM: Implications for the Surgical Oncologist , 2017, Annals of Surgical Oncology.
[14] S. Roman,et al. Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer. , 2017, Thyroid : official journal of the American Thyroid Association.
[15] D. Chang,et al. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. , 2012, Surgery.
[16] A. Stojadinovic,et al. Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. , 2014, Thyroid : official journal of the American Thyroid Association.
[17] Nancy D Perrier,et al. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? , 2017, Thyroid : official journal of the American Thyroid Association.
[18] Z. Hall. Cancer , 1906, The Hospital.
[19] P. Rosário. Eighth edition of AJCC staging for differentiated thyroid cancer: Is stage I appropriate for T4/N1b patients aged 45–55 years? , 2017, Endocrine.
[20] J. Shah,et al. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer , 2016, Annals of Surgical Oncology.
[21] C. Benbassat,et al. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study. , 2017, Thyroid : official journal of the American Thyroid Association.
[22] J. Shah,et al. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. , 2016, Thyroid : official journal of the American Thyroid Association.
[23] J. Shah,et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. , 2010, Thyroid : official journal of the American Thyroid Association.
[24] S. Roman,et al. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. , 2017, Thyroid : official journal of the American Thyroid Association.
[25] Nancy D Perrier,et al. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2018, CA: a cancer journal for clinicians.
[26] E. Kaplan,et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. , 2013, Surgery.